Product Information
SOLU-CORTEF 250 MG ACT-O-VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $37.9160 per EA under NDC 00009001306. Its NADAC has been published 7 times since Nov 20, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
250 mg/2mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009001306
Classification
Brand
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
12/18/2024
Active Ingredients
HYDROCORTISONE SODIUM SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA009866FDA Approved
Before 1982
TE Code
AP
On Market Since
4/27/1955
Pharmacological Classes
Price Statistics
The NADAC for SOLU-CORTEF 250 MG ACT-O-VIAL has been published 7 times since Nov 20, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $37.9160 per EA |
|---|---|
| All-time high | $37.9160 (Jan 1, 2025) |
| All-time low | $37.9160 (Nov 20, 2024) |
| Median price | $37.9160 |
| Average price | $37.9160 |
| Largest weekly change | 0.0% (Nov 27, 2024) |
| Weeks tracked | 7 |
| Tracking since | Nov 20, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Jan 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SOLU-CORTEF 250 MG ACT-O-VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SOLU-CORTEF 250 MG ACT-O-VIAL, manufactured by Pharmacia & Upjohn Company LLC, is $37.9160 per EA (NDC 00009001306), effective Jan 1, 2025.
How has the price of SOLU-CORTEF 250 MG ACT-O-VIAL changed over time?
Over the history we have for it, the NADAC for SOLU-CORTEF 250 MG ACT-O-VIAL has held within roughly two percent of its current level. It has been tracked across 7 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for SOLU-CORTEF 250 MG ACT-O-VIAL?
Since Nov 20, 2024, the NADAC for SOLU-CORTEF 250 MG ACT-O-VIAL has ranged from a low of $37.9160 (Nov 20, 2024) to a high of $37.9160 (Jan 1, 2025), with a median of $37.9160 per EA.
Are there cheaper alternatives to SOLU-CORTEF 250 MG ACT-O-VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SOLU-CORTEF 250 MG ACT-O-VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures SOLU-CORTEF 250 MG ACT-O-VIAL?
SOLU-CORTEF 250 MG ACT-O-VIAL (NDC 00009001306) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.